Rapid Micro Biosystems (RPID) Other financing activities (2020 - 2021)

Rapid Micro Biosystems' (RPID) quarterly Other financing activities came in at $1.5 million in Q2 2021, up 496.11% year-on-year from $257000.0 in Q2 2020, and down 43.26% quarter-over-quarter from $2.7 million in Q1 2021.

Rapid Micro Biosystems (RPID) Other financing activities (2020 - 2021) Analysis & Trends

Rapid Micro Biosystems has disclosed Other financing activities across 2 years of filings, most recently posting $1.5 million for Q2 2021.

  • Other financing activities for Q2 2021 came in at $1.5 million, up 496.11% year-over-year; the trailing twelve-month figure through Dec 2025 was $4.2 million (changed 0.42% YoY), and the FY2025 annual result was $878000.0, changed N/A from the prior year.
  • Other financing activities came in at $1.5 million for Q2 2021 at Rapid Micro Biosystems, down from $2.7 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $2.7 million in Q1 2021 to a low of $18000.0 in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Rapid Micro Biosystems 77.24 Mn 54.29 Mn 371,000.00

Historic Data

Download Data
DateValue
Jun 30, 2021 1.53 Mn
Jun 30, 2021 1.53 Mn
Mar 31, 2021 2.70 Mn
Mar 31, 2021 2.70 Mn
Dec 31, 2020 18,000.00
Dec 31, 2020 18,000.00
Jun 30, 2020 257,000.00
Jun 30, 2020 257,000.00